Serum glucagon concentration and hyperinsulinaemia influence renal haemodynamics and urinary protein loss in normotensive patients with central obesity

被引:20
作者
Solerte, SB
Rondanelli, M
Giacchero, R
Stabile, M
Lovati, E
Cravello, L
Pontiggia, B
Vignati, G
Ferrari, E
Fioravanti, M
机构
[1] Univ Pavia, Sch Endocrinol & Metab, Dept Internal Med, I-27100 Pavia, Italy
[2] Univ Pavia, Chair Geriatr, I-27100 Pavia, Italy
[3] Osped Magenta, Lab Endocrine & Metab Dis, Magenta, Italy
关键词
obesity; body fat distribution; glucagon; insulin; NEFA; glomerular filtration rate; albuminuria; proteinuria; alpha; 1; microglobulin; arterial blood pressure; cardiovascular disease;
D O I
10.1038/sj.ijo.0801032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: Insulin-resistance syndrome and hyperinsulinaemia are linked with cardiovascular disease (CVD) in the obese population, In particular, cardiovascular risk is more frequent in central obesity and is associated with microalbuminuria (MA). MA and changes of glomerular permeability to proteins in obesity might be related with renal haemodynamic modifications (that is glomerular hyperfiltration). Since glucagon is physiologically involved in renal haemodynamic regulation, the purpose of this study was to examine whether changes of circulating glucagon levels might haemodynamically induce MA and proteinuria in patients with central obesity, SUBJECTS: Forty normotensive obese out-patients, 22 with central (CO group) and 18 with peripheral (PO group) body fat distribution and 11 healthy subjects. MEASUREMENTS: Serum insulin and glucagon concentrations (fasting and after oral glucose tolerance test (OGTT)) by radio immune assay (RIA); glomerular filtration rate (GFR, isotopic); total clearances and urinary excretion rates of albumin (AER), IgG (IgGER) and alpha 1 microglobulin (computerized immunonephelometry). RESULTS: GFR and insulin concentrations (fasting and during OGTT) were higher in the CO than the PO group. Fasting glucagon concentrations were increased, and not physiologically suppressed during OGTT in patients with CO (fasting, P < 0.05; OGTT 60 and 120 min, P < 0.001 vs PO group). Moreover, glucagon concentrations were significantly correlated with GFR in the CO group (fasting, r = 0.49, P < 0.05; 60 min after OGTT, r = 0.58, P < 0.01); whereas no correlations were found in the PO group. Higher AER (P < 0.001), IgGER (P < 0.001) and alpha 1 microglobulin (P < 0.05) urinary concentrations were found in patients with CO than in the PO group. CONCLUSIONS: The increase of serum glucagon concentrations may be associated with the enhancement of GFR in patients with central obesity. Glomerular hyperfiltration might influence the development of MA and of proteinuria by means of a haemodynamic mechanism so contributing to increase the risk of renal microvascular complications and of CVD in central obesity.
引用
收藏
页码:997 / 1003
页数:7
相关论文
共 45 条
  • [1] INFLUENCE OF GLUCAGON ON GFR AND ON UREA AND ELECTROLYTE EXCRETION - DIRECT AND INDIRECT EFFECTS
    AHLOULAY, M
    DECHAUX, M
    LABORDE, K
    BANKIR, L
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (02): : F225 - F235
  • [2] BASDEVANT A, 1994, INT J OBESITY, V18, P806
  • [3] BJORNTORP P, 1985, ANN CLIN RES, V17, P3
  • [4] REGULATION OF FREE FATTY-ACID METABOLISM BY GLUCAGON
    CARLSON, MG
    SNEAD, WL
    CAMPBELL, PJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (01) : 11 - 15
  • [5] MICROALBUMINURIA IN OBESE SUBJECTS
    CASSUTO, D
    BASDEVANT, A
    GIBAULT, T
    ALTMAN, JJ
    RAISON, J
    GUYGRAND, B
    [J]. HORMONE AND METABOLIC RESEARCH, 1992, 24 (06) : 302 - 303
  • [6] CHRISTIANSEN JS, 1981, DIABETOLOGIA, V20, P199
  • [7] COHEN AJ, 1989, AM J PHYSIOL, V26, pF580
  • [8] CREPALDI G, 1991, INT J OBESITY, V15, P781
  • [9] ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS
    DECKERT, T
    FELDTRASMUSSEN, B
    BORCHJOHNSEN, K
    JENSEN, T
    KOFOEDENEVOLDSEN, A
    [J]. DIABETOLOGIA, 1989, 32 (04) : 219 - 226
  • [10] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194